Ljubica Zotovic

Ljubica Zotovic

Auto-generated profile, based on publicly available information

Ljubica Zotovic

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2025 in Journal of Alzheimer's Disease Reports
Verified
Journal Article
Open access
CLCarl Froilan D Leochico
Carl Froilan D Leochico
EREkaterina Rogaeva
Ekaterina Rogaeva
LZLjubica Zotovic
Ljubica Zotovic
AOAna Luiza Pinto Oliveira
Ana Luiza Pinto Oliveira
TLTina Le
Tina Le
SMSara B Mitchell
Sara B Mitchell
Familial early-onset Alzheimer's disease (EOAD) is a rare form of dementia often caused by autosomal dominant mutations in APP , PSEN1, or PSEN2 . We report a novel PSEN2 missense variant (c.359T > G, p.Ile120Ser) that has been detected in four siblings; three of whom are affected by predominantly amnestic EOAD or mild cognitive impairment in their fifties (supported by neuroimaging biomarkers), while the youngest sibling is currently asymptomatic at age 50. Two of the siblings were also heterozygous for a variant in PSEN1 (c.118_120del, p.Asp40del). Between the two genes, the PSEN2 variant was deemed to be likely pathogenic based on segregation with EOAD, imaging biomarker analyses, and bioinformatic analyses. Reporting genetic findings in familial EOAD cases can help in classifying their pathogenic significance and improving genetic conceptualization within Alzheimer's disease.